Review



cd45  (Bio-Techne corporation)


Bioz Verified Symbol Bio-Techne corporation is a verified supplier
Bioz Manufacturer Symbol Bio-Techne corporation manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Bio-Techne corporation cd45
    Phenotype characterization of partially hypomethylated MSCs. The expression of CD105, CD90, <t>CD45,</t> and CD34 was analyzed by flow cytometry for normally methylated cells ( A ), cells treated with 2.5 μM ( B ), or 5 μM ( C ) of 5-Aza-dC. No significant differences were observed in the expression of CD markers between DMSO-treated cells and cells treated with 5-Aza-dC ( D ). Bars represent the average (±SD) of three independent measurements, ns , not significant. Comparison between means was performed by one-way ANOVA test
    Cd45, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 96/100, based on 331 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45/product/Bio-Techne corporation
    Average 96 stars, based on 331 article reviews
    cd45 - by Bioz Stars, 2026-02
    96/100 stars

    Images

    1) Product Images from "Conservative Hypomethylation of Mesenchymal Stem Cells and Their Secretome Restored the Follicular Development in Cisplatin-Induced Premature Ovarian Failure Mice"

    Article Title: Conservative Hypomethylation of Mesenchymal Stem Cells and Their Secretome Restored the Follicular Development in Cisplatin-Induced Premature Ovarian Failure Mice

    Journal: Reproductive Sciences

    doi: 10.1007/s43032-023-01389-4

    Phenotype characterization of partially hypomethylated MSCs. The expression of CD105, CD90, CD45, and CD34 was analyzed by flow cytometry for normally methylated cells ( A ), cells treated with 2.5 μM ( B ), or 5 μM ( C ) of 5-Aza-dC. No significant differences were observed in the expression of CD markers between DMSO-treated cells and cells treated with 5-Aza-dC ( D ). Bars represent the average (±SD) of three independent measurements, ns , not significant. Comparison between means was performed by one-way ANOVA test
    Figure Legend Snippet: Phenotype characterization of partially hypomethylated MSCs. The expression of CD105, CD90, CD45, and CD34 was analyzed by flow cytometry for normally methylated cells ( A ), cells treated with 2.5 μM ( B ), or 5 μM ( C ) of 5-Aza-dC. No significant differences were observed in the expression of CD markers between DMSO-treated cells and cells treated with 5-Aza-dC ( D ). Bars represent the average (±SD) of three independent measurements, ns , not significant. Comparison between means was performed by one-way ANOVA test

    Techniques Used: Expressing, Flow Cytometry, Methylation, Comparison



    Similar Products

    96
    Bio-Techne corporation cd45
    Phenotype characterization of partially hypomethylated MSCs. The expression of CD105, CD90, <t>CD45,</t> and CD34 was analyzed by flow cytometry for normally methylated cells ( A ), cells treated with 2.5 μM ( B ), or 5 μM ( C ) of 5-Aza-dC. No significant differences were observed in the expression of CD markers between DMSO-treated cells and cells treated with 5-Aza-dC ( D ). Bars represent the average (±SD) of three independent measurements, ns , not significant. Comparison between means was performed by one-way ANOVA test
    Cd45, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45/product/Bio-Techne corporation
    Average 96 stars, based on 1 article reviews
    cd45 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    88
    Novus Biologicals cd45
    Antibodies used in the study
    Cd45, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45/product/Novus Biologicals
    Average 88 stars, based on 1 article reviews
    cd45 - by Bioz Stars, 2026-02
    88/100 stars
      Buy from Supplier

    90
    Bio-Techne corporation cd45 antibody (ox-1) - bsa free
    Antibodies used in the study
    Cd45 Antibody (Ox 1) Bsa Free, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45 antibody (ox-1) - bsa free/product/Bio-Techne corporation
    Average 90 stars, based on 1 article reviews
    cd45 antibody (ox-1) - bsa free - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    96
    Bio-Techne corporation anti cd45
    Nanoparticles’ (NPs) properties characterization. After fabrication, NPs were characterized for their physicochemical and biological properties using dynamic light scattering. No significant changes in A) size and B) polydispersity index (PDI) were observed. However, a significant decrease in C) zeta potential for leukosomes (Leuko) compared to liposomes (Lipo) was noticed. D) Representative cryo‐TEM images of Lipo and Leuko verified that no morphological changes occurred following membrane protein integration to the NPs. Scale bars = 100 nm. E) Western blots for leukocyte membrane protein markers: CD11b, CD18, CD47, and <t>CD45</t> indicated their membrane integration in Leuko but absence in Lipo. Results are shown as mean ± SEM. Unpaired t‐test was used to determine statistical probabilities * p ≤ 0.05 among means considered statistically significant, n = 5.
    Anti Cd45, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd45/product/Bio-Techne corporation
    Average 96 stars, based on 1 article reviews
    anti cd45 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    88
    Novus Biologicals nb100
    Antibodies used in the study
    Nb100, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nb100/product/Novus Biologicals
    Average 88 stars, based on 1 article reviews
    nb100 - by Bioz Stars, 2026-02
    88/100 stars
      Buy from Supplier

    90
    Novus Biologicals ptprc novus biologicals nb10064895
    Antibodies used in the study
    Ptprc Novus Biologicals Nb10064895, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ptprc novus biologicals nb10064895/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    ptprc novus biologicals nb10064895 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    96
    Bio-Techne corporation anti cd45 mab
    Antibodies used in the study
    Anti Cd45 Mab, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd45 mab/product/Bio-Techne corporation
    Average 96 stars, based on 1 article reviews
    anti cd45 mab - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    90
    Novus Biologicals mouse anti cd45 rat
    Antibodies used in the study
    Mouse Anti Cd45 Rat, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti cd45 rat/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    mouse anti cd45 rat - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Phenotype characterization of partially hypomethylated MSCs. The expression of CD105, CD90, CD45, and CD34 was analyzed by flow cytometry for normally methylated cells ( A ), cells treated with 2.5 μM ( B ), or 5 μM ( C ) of 5-Aza-dC. No significant differences were observed in the expression of CD markers between DMSO-treated cells and cells treated with 5-Aza-dC ( D ). Bars represent the average (±SD) of three independent measurements, ns , not significant. Comparison between means was performed by one-way ANOVA test

    Journal: Reproductive Sciences

    Article Title: Conservative Hypomethylation of Mesenchymal Stem Cells and Their Secretome Restored the Follicular Development in Cisplatin-Induced Premature Ovarian Failure Mice

    doi: 10.1007/s43032-023-01389-4

    Figure Lengend Snippet: Phenotype characterization of partially hypomethylated MSCs. The expression of CD105, CD90, CD45, and CD34 was analyzed by flow cytometry for normally methylated cells ( A ), cells treated with 2.5 μM ( B ), or 5 μM ( C ) of 5-Aza-dC. No significant differences were observed in the expression of CD markers between DMSO-treated cells and cells treated with 5-Aza-dC ( D ). Bars represent the average (±SD) of three independent measurements, ns , not significant. Comparison between means was performed by one-way ANOVA test

    Article Snippet: Phycoerthrin (PE)-conjugated mouse monoclonal antibodies of CD90, and CD34 or FITC-conjugated monoclonal antibodies of CD105 and CD45 were from (Biotechne R&D System, MN, USA).

    Techniques: Expressing, Flow Cytometry, Methylation, Comparison

    Antibodies used in the study

    Journal: BMC Molecular and Cell Biology

    Article Title: Transcriptome and proteome profiling reveal complementary scavenger and immune features of rat liver sinusoidal endothelial cells and liver macrophages

    doi: 10.1186/s12860-020-00331-9

    Figure Lengend Snippet: Antibodies used in the study

    Article Snippet: CD45 (OX-1) , CD45, PTPRC , Novus Biologicals , NB100–64895 , 10 μg/ml.

    Techniques: Concentration Assay, Flow Cytometry, Staining, FACS

    Expression of the leukocyte marker PTPRC/CD45 in rat LSECs. a : Ptprc/Cd45 mRNA and PTPRC/CD45 protein expression as obtained from RNA-seq (log 2 RPKM) and label-free proteomics (log 2 iBAQ) in KCs (red dots) and LSECs (blue triangles). b-f : Representative sequential gating during flow cytometry analysis of rat non-parenchymal liver cells ( n = 4). Cells were labeled with antibodies to SE-1/FcγRIIb2, CD31, and CD45 (listed in Table ). b : Gating based on the FSC-A vs FSC-H profile to exclude duplets and aggregates from the subsequent analysis. c : Gating on the SSC-A vs FSC-A profile to select small cells with limited complexity (enriched in endothelial cells). d : Gating to select DAPI negative live cells. e-f : LSECs were then identified as SE-1-Alexa488 + cells ( e ), and the biexponential CD45-PE/CD31-APC of events ( f ) were used to display and select the CD45 + CD31 + subsets of LSECs. FMOs (used for gating), and single antibody staining controls are shown in Additional file . g : Average of the percentage of viable parent populations observed in 4 biological replicates (±standard deviation, SD)

    Journal: BMC Molecular and Cell Biology

    Article Title: Transcriptome and proteome profiling reveal complementary scavenger and immune features of rat liver sinusoidal endothelial cells and liver macrophages

    doi: 10.1186/s12860-020-00331-9

    Figure Lengend Snippet: Expression of the leukocyte marker PTPRC/CD45 in rat LSECs. a : Ptprc/Cd45 mRNA and PTPRC/CD45 protein expression as obtained from RNA-seq (log 2 RPKM) and label-free proteomics (log 2 iBAQ) in KCs (red dots) and LSECs (blue triangles). b-f : Representative sequential gating during flow cytometry analysis of rat non-parenchymal liver cells ( n = 4). Cells were labeled with antibodies to SE-1/FcγRIIb2, CD31, and CD45 (listed in Table ). b : Gating based on the FSC-A vs FSC-H profile to exclude duplets and aggregates from the subsequent analysis. c : Gating on the SSC-A vs FSC-A profile to select small cells with limited complexity (enriched in endothelial cells). d : Gating to select DAPI negative live cells. e-f : LSECs were then identified as SE-1-Alexa488 + cells ( e ), and the biexponential CD45-PE/CD31-APC of events ( f ) were used to display and select the CD45 + CD31 + subsets of LSECs. FMOs (used for gating), and single antibody staining controls are shown in Additional file . g : Average of the percentage of viable parent populations observed in 4 biological replicates (±standard deviation, SD)

    Article Snippet: CD45 (OX-1) , CD45, PTPRC , Novus Biologicals , NB100–64895 , 10 μg/ml.

    Techniques: Expressing, Marker, RNA Sequencing Assay, Flow Cytometry, Labeling, Staining, Standard Deviation

    Nanoparticles’ (NPs) properties characterization. After fabrication, NPs were characterized for their physicochemical and biological properties using dynamic light scattering. No significant changes in A) size and B) polydispersity index (PDI) were observed. However, a significant decrease in C) zeta potential for leukosomes (Leuko) compared to liposomes (Lipo) was noticed. D) Representative cryo‐TEM images of Lipo and Leuko verified that no morphological changes occurred following membrane protein integration to the NPs. Scale bars = 100 nm. E) Western blots for leukocyte membrane protein markers: CD11b, CD18, CD47, and CD45 indicated their membrane integration in Leuko but absence in Lipo. Results are shown as mean ± SEM. Unpaired t‐test was used to determine statistical probabilities * p ≤ 0.05 among means considered statistically significant, n = 5.

    Journal: Advanced Functional Materials

    Article Title: Biomimetic Nanoparticles as a Theranostic Tool for Traumatic Brain Injury

    doi: 10.1002/adfm.202100722

    Figure Lengend Snippet: Nanoparticles’ (NPs) properties characterization. After fabrication, NPs were characterized for their physicochemical and biological properties using dynamic light scattering. No significant changes in A) size and B) polydispersity index (PDI) were observed. However, a significant decrease in C) zeta potential for leukosomes (Leuko) compared to liposomes (Lipo) was noticed. D) Representative cryo‐TEM images of Lipo and Leuko verified that no morphological changes occurred following membrane protein integration to the NPs. Scale bars = 100 nm. E) Western blots for leukocyte membrane protein markers: CD11b, CD18, CD47, and CD45 indicated their membrane integration in Leuko but absence in Lipo. Results are shown as mean ± SEM. Unpaired t‐test was used to determine statistical probabilities * p ≤ 0.05 among means considered statistically significant, n = 5.

    Article Snippet: Antibodies for western blot rat anti‐CD11b (MAB11241), goat anti‐CD18 (AF2618), rabbit anti‐CD45 (EPR20033), goat anti‐CD47 (ab108415), anti‐rabbit IgG‐HRP, anti‐goat IgG‐HRP, and anti‐rat IgG (Bio‐Techne Corporation, Minnesota, USA).

    Techniques: Zeta Potential Analyzer, Liposomes, Membrane, Western Blot

    Antibodies used in the study

    Journal: BMC Molecular and Cell Biology

    Article Title: Transcriptome and proteome profiling reveal complementary scavenger and immune features of rat liver sinusoidal endothelial cells and liver macrophages

    doi: 10.1186/s12860-020-00331-9

    Figure Lengend Snippet: Antibodies used in the study

    Article Snippet: CD45 (OX-1) , CD45, PTPRC , Novus Biologicals , NB100–64895 , 10 μg/ml.

    Techniques: Concentration Assay, Flow Cytometry, Staining, FACS